MET and rectal carcinoma: They demonstrated that c-MET protein overexpression is related to tumour recurrence and is associated with worse prognosis and suggested that inhibition of c-MET is a potential new strategy for reduction of distant recurrence of rectal carcinoma after preoperative chemotherapy.